TRAIL-NP hybrids for cancer therapy: a review. (Q39263297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

TRAIL-NP hybrids for cancer therapy: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

H Belkahla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

T Gharbi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

S Ammar

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

1 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

5755-5768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

Defining the critical hurdles in cancer immunotherapy

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Death receptors as targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL in cancer therapy: present and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Tumor necrosis factor receptor superfamily members and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

CD8 T cells utilize TRAIL to control influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL Is a Novel Antiviral Protein against Dengue Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Solution structure of the tumor necrosis factor receptor-1 death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Immunoglobulin Fc domain fusion to TRAIL significantly prolongs its plasma half-life and enhances its antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Nanovectorization of TRAIL with single wall carbon nanotubes enhances tumor cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL-induced apoptosis is preferentially mediated via TRAIL receptor 1 in pancreatic carcinoma cells and profoundly enhanced by XIAP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Antitumor immunity by magnetic nanoparticle-mediated hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Single Particle and PET-based Platform for Identifying Optimal Plasmonic Nano-Heaters for Photothermal Cancer Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Evaluation of uptake and distribution of gold nanoparticles in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Natural inorganic nanoparticles--formation, fate, and toxicity in the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Designing nanoparticle translocation through cell membranes by varying amphiphilic polymer coatings

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Gold nanoparticles coated with polysarcosine brushes to enhance their colloidal stability and circulation time in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Cancer Theranostics with Near-Infrared Light-Activatable Multimodal Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Catechol derivatives-coated Fe3O4 and gamma-Fe2O3 nanoparticles as potential MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

The golden age: gold nanoparticles for biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

In vivo molecular and cellular imaging with quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Label-free fluorimetric detection of CEA using carbon dots derived from tomato juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A DNA-based method for rationally assembling nanoparticles into macroscopic materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

An immunocolloid method for the electron microscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A multidentate peptide for stabilization and facile bioconjugation of gold nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

The use of gold nanoparticles in diagnostics and detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Gold nanoshell bioconjugates for molecular imaging in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Controlled release of Rituximab from gold nanoparticles for phototherapy of malignant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Gold hybrid nanoparticles for targeted phototherapy and cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Multimodality imaging probes: design and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A Chelator-Free Multifunctional [64Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Silica-based nanocapsules: synthesis, structure control and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Imaging transgene expression with radionuclide imaging technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

In vivo non invasive molecular imaging for immune cell tracking in small animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

In vitro and in vivo chemo-phototherapy of magnetic TiO2 drug delivery system formed by pH-sensitive coordination bond

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Cancer optical imaging using fluorescent nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Lanthanide-loaded liposomes for multimodality imaging and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Liposomes: applications in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Liposomal drug delivery systems: an update review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Synthesis and surface functionalization of silica nanoparticles for nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Nonporous Silica Nanoparticles for Nanomedicine Application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Advances and Challenges of Liposome Assisted Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Current status of pH-sensitive liposomes in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Hyperthermia mediated liposomal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Reversible covalent chemistry in drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Liposomes in ultrasonic drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Ultrasonic drug delivery--a general review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Chemically Functionalized Carbon Nanotubes as Substrates for Neuronal Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Smart nanotubes for bioseparations and biocatalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Covalently functionalized nanotubes as nanometre-sized probes in chemistry and biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Mesoporous silica nanoparticles in target drug delivery system: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Multifunctional Mesoporous Silica Nanocomposite Nanoparticles for Theranostic Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Silica-based multimodal/multifunctional nanoparticles for bioimaging and biosensing applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Aqueous latex/ceramic nanoparticle dispersions: colloidal stability and coating properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Preparation and Characterization of Apo2L/TNF-Related Apoptosis-Inducing Ligand–Loaded Human Serum Albumin Nanoparticles with Improved Stability and Tumor Distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Superior serum half life of albumin tagged TNF ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Targeted protein functionalization using His-tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Systemic delivery and activation of the TRAIL gene in lungs, with magnetic nanoparticles of chitosan controlled by an external magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis by hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Zinc substituted ferrite nanoparticles with Zn0.9Fe2.1O4 formula used as heating agents for in vitro hyperthermia assay on glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Thermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following γ-Fe2O3 NPs internalization and magnetic field application

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

High potential of Mn-doped ZnS nanoparticles with different dopant concentrations as novel MRI contrast agents: synthesis and in vitro relaxivity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Nanotechnology: Carbon nanotubes with DNA recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

New manganite-based mediators for self-controlled magnetic heating

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

(⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

Towards Solutions of Single-Walled Carbon Nanotubes in Common Solvents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7NR01469D

21 January 2018

Identifiers

DOI

10.1039/C7NR01469D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28443893%20AND%20SRC:MED&resulttype=core&format=json